Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06472297 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring in Prediabetes

A NA study of PreDiabetes, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT06472297: Completed NA study of PreDiabetes, sponsored by University of Southern California.

NCT06472297 is a NA study of PreDiabetes that has completed, run by University of Southern California. The registered enrollment target is 23 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06472297, a NA study of PreDiabetes, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes.

Primary Outcome

Mean glucose was derived from continuous glucose monitoring (CGM) data obtained from the Dexcom Clarity system. Raw glucose values were processed and analyzed using the R statistical software package iglu to generate the full CGM variability metrics panel. For each participant, mean glucose was calculated separately for each 10-day assessment period. The outcome measure represents the change in mean glucose, defined as the difference between the baseline (Phase A) 10-day assessment period and th

Conditions Studied

Interventions

  • DEVICE The continuous glucose monitoring system

Study Locations (1)

California

  • Southern California Center for Latino Health SCCLH - Los Angeles

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2024-06-01
Est. Completion 2024-09-30
Phase NA
University of Southern California

617 total trials

What the finished NCT06472297 record still lists

NCT06472297 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (97% lower).

The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which The continuous glucose monitoring system is the first listed.

NCT06472297 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06472297 about?

NCT06472297 is a clinical study titled "Continuous Glucose Monitoring in Prediabetes". The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. Th...

What is the current status of trial NCT06472297?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2024-06-01. Estimated completion is 2024-09-30.

What conditions does trial NCT06472297 study?

This clinical trial studies the following conditions: PreDiabetes.

What interventions are being tested in trial NCT06472297?

The interventions under investigation include: The continuous glucose monitoring system (DEVICE).

Who is sponsoring clinical trial NCT06472297?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06472297 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06472297's enrollment target sits among peer trials

23 130th of 149 higher than 20 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06472297, the US trial registry maintained by the National Library of Medicine. NCT06472297 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.